The pharmacology of orforglipron, an orally bioavailable, non-peptide agonist of the GLP-1 receptor - Matthew Coghlan

Name: The pharmacology of orforglipron, an orally bioavailable, non-peptide agonist of the GLP-1 receptor - Matthew Coghlan
Start: 2026-10-14T16:30
End: 2026-10-14T17:00
Location: ExCeL London

ELRIG Drug Discovery 2026 · 14 October 2026 · 16:30–17:00 · Exhibition Hall Theatre

The pharmacology of orforglipron, an orally bioavailable, non-peptide agonist of the GLP-1 receptor - Matthew Coghlan was a session at ELRIG Drug Discovery 2026 on 14 October 2026 in London, with 1 speaker on record.

Speakers

Matthew Coghlan — Speaker Vice President, Eli Lilly And Company